274 related articles for article (PubMed ID: 833274)
1. Gastric emptying and secretion in Zollinger-Ellison syndrome.
Dubois A; Eerdewegh PV; Gardner JD
J Clin Invest; 1977 Feb; 59(2):255-63. PubMed ID: 833274
[TBL] [Abstract][Full Text] [Related]
2. Salivary and gastric epidermal growth factor in patients with Zollinger-Ellison syndrome: its protective potential.
Sarosiek J; Jensen RT; Maton PN; Peura DA; Harlow D; Feng T; McCallum RW; Pisegna JR
Am J Gastroenterol; 2000 May; 95(5):1158-65. PubMed ID: 10811321
[TBL] [Abstract][Full Text] [Related]
3. [Hyperacidity and hypersecretion of the stomach stump--a possibility of Zollinger-Ellison syndrome].
Lityński M; Altman W
Pol Tyg Lek; 1968 Oct; 23(44):1698-700. PubMed ID: 5701469
[No Abstract] [Full Text] [Related]
4. [Gastric secretion in Zollinger-Ellison syndrome].
Konturek S; Biernat J; Konturek D
Pol Tyg Lek; 1972 Sep; 27(36):1385-7. PubMed ID: 5078725
[No Abstract] [Full Text] [Related]
5. Effect of vagotomy in Zollinger-Ellison syndrome.
Richardson CT; Feldman M; McClelland RN; Dickerman RM; Kumpuris D; Fordtran JS
Gastroenterology; 1979 Oct; 77(4 Pt 1):682-6. PubMed ID: 467924
[TBL] [Abstract][Full Text] [Related]
6. [Exploration of the gastric acid secretion in man. Methods and results].
Lambert R; Granthil C; Minaire Y
Lyon Med; 1972 Mar; 227(6):545-52. PubMed ID: 5053997
[No Abstract] [Full Text] [Related]
7. Reliability of symptoms in assessing control of gastric acid secretion in patients with Zollinger-Ellison syndrome.
Raufman JP; Collins SM; Pandol SJ; Korman LY; Collen MJ; Cornelius MJ; Feld MK; McCarthy DM; Gardner JD; Jensen RT
Gastroenterology; 1983 Jan; 84(1):108-13. PubMed ID: 6128284
[TBL] [Abstract][Full Text] [Related]
8. [Effect of depot somatostatin on gastrin and stomach secretion in normal subjects and in patients with Zollinger-Ellison syndrome].
Raptis S; Dollinger HC; Escobar-Jimenez F; Pfeiffer EF
Verh Dtsch Ges Inn Med; 1976; 82 Pt 1():1006-9. PubMed ID: 1029163
[No Abstract] [Full Text] [Related]
9. Pancreatic function in patients with the Zollinger-Ellison syndrome. Observations concerning acid-bicarbonate secretion ratios.
Dreiling DA; Greenstein A
Med Chir Dig; 1972; 1(1):1-4. PubMed ID: 5054001
[No Abstract] [Full Text] [Related]
10. Long-term treatment with histamine H2-receptor antagonists in Zollinger-Ellison syndrome.
Lamers CB; Festen HP; van Tongeren JH
Am J Gastroenterol; 1978 Sep; 70(3):286-91. PubMed ID: 717379
[TBL] [Abstract][Full Text] [Related]
11. [Dose-response curves obtained with metiamide in the Zollinger-Ellison syndrome].
Mignon M; Galmiche JP; Bonfils S
Biol Gastroenterol (Paris); 1975; 8(3):239-44. PubMed ID: 764881
[No Abstract] [Full Text] [Related]
12. Treatment of patients with Zollinger-Ellison syndrome.
Mignon M; Pospai D; Forestier S; Vatier J; Vallot T
Clin Ther; 1993; 15 Suppl B():22-31. PubMed ID: 8205592
[TBL] [Abstract][Full Text] [Related]
13. Metiamide treatment in five patients with Zollinger-Ellison syndrome.
Bonfils S; Bernier JJ; Mignon M; Lambert R; Bernades P; L'Hirondel C; Accary JP; Kloeti G
Digestion; 1977; 15(1):43-52. PubMed ID: 838177
[TBL] [Abstract][Full Text] [Related]
14. Clinical recovery owing to target parietal cell failure in a patient with Zollinger-Ellison syndrome.
Wiersinga WM; Tytgat GN
Gastroenterology; 1977 Dec; 73(6):1413-7. PubMed ID: 199524
[TBL] [Abstract][Full Text] [Related]
15. Gastric secretion in duodenal ulcer, with particular reference to the diagnosis of Zollinger-Ellison syndrome.
Kaye MD; Rhodes J; Beck P
Gastroenterology; 1970 Apr; 58(4):476-81. PubMed ID: 4314536
[No Abstract] [Full Text] [Related]
16. Inhibition of gastric acid secretion by metiamide in Zollinger-Ellison syndrome.
Mainardi M; Maxwell V; Sturdevant RA; Isenberg JI
Am J Dig Dis; 1975 Mar; 20(3):280-1. PubMed ID: 1124750
[No Abstract] [Full Text] [Related]
17. Gastric cycle nucleotide concentration in health and disease. Response to secretagogues and role of circulating gastrin and intragastric acid secretion.
Levine RA; Schwartzel EH; Bachman S; Talev JN
Gastroenterology; 1977 Oct; 73(4 Pt 1):737-45. PubMed ID: 196973
[No Abstract] [Full Text] [Related]
18. [Stimulation of gastric secretion after calcium infusion in the Zollinger-Ellison syndrome].
Basso N; Passaro E; Lezoche E; Mennini G; Speranza V
J Chir (Paris); 1972; 103(5):493-8. PubMed ID: 4653425
[No Abstract] [Full Text] [Related]
19. Effect of oral and intravenous 16,16-dimethyl prostaglandin E2 in duodenal ulcer and Zollinger-Ellison syndrome patients.
Ippoliti AF; Isenberg JI; Hagie L
Gastroenterology; 1981 Jan; 80(1):55-9. PubMed ID: 7450412
[TBL] [Abstract][Full Text] [Related]
20. An open-label study of rabeprazole in patients with Zollinger-Ellison syndrome or idiopathic gastric acid hypersecretion.
Morocutti A; Merrouche M; Bjaaland T; Humphries T; Mignon M
Aliment Pharmacol Ther; 2006 Nov; 24(10):1439-44. PubMed ID: 17081164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
